Use of 4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno[2,3-D]pyrimidine for the treatment of pain

Details for Australian Patent Application No. 2002307872 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 0112494.0 22.05.01 GB

8 May 2003 Application Open to Public Inspection

Published as AU-B-2002307872

7 October 2004 Application Accepted

Published as AU-B-2002307872

27 January 2005 Opposition Lodged

Dynogen Pharmaceuticals Inc. has lodged an opposition against Arachnova Therapeutics Ltd.

9 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.